Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong · Delayed Price · Currency is HKD 65.60
-0.35 (-0.53%)
May 28, 2026, 10:19 AM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 35.84 billion as of May 27, 2026. Its market cap has increased by 78.00% in one year.
Market Cap
35.84B
Enterprise Value
38.91B
Revenue
7.42B
Ranking
n/a
PE Ratio
39.25
Stock Price
65.60
Market Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has increased from 26.66B to 35.84B, an increase of 34.45%. That is a compound annual growth rate of 4.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 35.84B | 15.60% |
| Dec 31, 2025 | 31.01B | 140.72% |
| Dec 31, 2024 | 12.88B | 70.50% |
| Dec 29, 2023 | 7.55B | 8.59% |
| Dec 30, 2022 | 6.96B | -41.95% |
| Dec 31, 2021 | 11.98B | -53.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RemeGen | 65.18B |
| 3SBio | 48.09B |
| Biocytogen Pharmaceuticals (Beijing) | 46.03B |
| Shanghai Junshi Biosciences | 38.80B |
| Genscript Biotech | 28.38B |
| InnoCare Pharma | 24.94B |
| Duality Biotherapeutics | 20.12B |
| Metis TechBio | 19.45B |